The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects
Abstract
The activities of complex I and complex II/III in platelet mitochondria are reduced in patients with early, untreated Parkinson's disease. Coenzyme Q 10 is the electron acceptor for complex I and complex II. We found that the level of coenzyme Q 10 was significantly lower in mitochondria from parkinsonian patients than in mitochondria from age‐ and sex‐matched control subjects and that the levels of coenzyme Q 10 and the activities of complex I and complex II/III were significantly correlated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this study, oral administration of CoQ10 in PD patients was well tolerated and resulted in significant, dose-dependent increases in plasma CoQ10 levels.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [159]
In the citing paper
“We found a significant reduction in CoQ10 levels in mitochondria isolated from platelets of PD patients, that directly correlated with a decrease in complex-I activity159.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [159]
Citations
Cites
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Biochemical, physiological and medical aspects of ubiquinone function
Ernster, L., & Dallner, G. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00028-3 · Cited by 1,246
Abnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
Fahn, S., & Cohen, G. (1992) · Annals of Neurology · doi:10.1002/ana.410320616 · Cited by 927
Oxygen radicals and the nervous system
Halliwell, B. B., & Gutteridge, J. M. C. (1985) · Trends in Neurosciences · doi:10.1016/0166-2236(85)90010-4 · Cited by 823
Schapira, A. H. V., Mann, V. M., Cooper, J. A. D., Dexter, D. T., Daniel, S. E., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05809.x · Cited by 673
Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., & Shults, C. W. (1995) · Annals of Neurology · doi:10.1002/ana.410370604 · Cited by 435
Self-citationLovastatin decreases coenzyme Q levels in humans.
Folkers, K., Langsjoen, P. H., Willis, R. A., Richardson, P. C., Xia, L., Ye, C. Q., & Tamagawa, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8931 · Cited by 426
Platelet mitochondria function in Parkinson's disease
Krige, D., Carroll, M. T., Cooper, J. A. D., MARSDEN, C. D., & Schapira, A. H. V. (1992) · Annals of Neurology · doi:10.1002/ana.410320612 · Cited by 358
Benecke, R., Strumper, P., & Weiss, H. (1993) · Brain · doi:10.1093/brain/116.6.1451 · Cited by 220
Research works printed but not linked: 1
- Gotz ME, 1996, Platelet coenzyme Q10 in Parkinson's disease, Mov Disord, 11, 127
Cited by
Sorted by citations
Items 301–324 of 324
Pharmacotherapy and Treatment of Parkinson's Disease
Au, W. L., & Calne, D. B. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn062
Genetic Risk Factors: Session V Summary and Research Needs
Farrer, M. J., & Richfield, E. K. (2001) · NeuroToxicology · doi:10.1016/s0161-813x(01)00087-0
García, E. M. (2001) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Koopman, H. J. M. (2013) · Utrecht University Repository (Utrecht University)
Rego, A. C., Cardoso, S. M., & Oliveira, C. R. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_9 · Cited by 1
Therapeutic Eeffect of Bone Marrow Stromal Cells & Coenzyme Q10 on Rat Models of Parkinson's Disease
Nezhadi, A., Ghazi, F., Rasouli, H., Bakhtiari, M., Zohreh, A. A., Marzban, M., & Mahdi, M. (2009)
Complementary and Alternative Medicine in Neurology
Kaufman, S. R., & Rubin, M. B. (2003) · Springer eBooks · doi:10.1007/978-3-662-05185-6_30
Experimental Models and New, Emerging Therapies for Parkinson Disease
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50012-7
Early (Uncomplicated) Parkinson's Disease
Horstink, M. W. I. M., TOLOSA, E. S., Bonuccelli, U., Deuschl, G., Friedman, A., Kaňovský, P., Larsen, J. O., Lees, A. J., Oertel, W. H., Poewe, W. H., et al. (2006) · Wiley eBooks · doi:10.1002/9780470753279.ch17
Baluchnejadmojarad, T., & Roghani, M. (2014) · DOAJ (DOAJ: Directory of Open Access Journals)
Medical treatment of Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00006-8
Effects of Coenzyme Q10 Supplementation on Elderly People
Yubero‐Serrano, E. M., Gutierrez-Mariscal, F. M., & López‐Miranda, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-45642-9_17
Central Nervous System ( CNS )
Sommer, D. B., & Goldstein, L. B. (2008) · Wiley Encyclopedia of Clinical Trials · doi:10.1002/9780471462422.eoct616
Kremens, D. E. (2013) · Informa Healthcare eBooks · doi:10.3109/9781841849096.017
Simmons, A. D. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00013-3
Liu, Y., & Yan, Y. (2022) · Journal of Innovations in Medical Research · doi:10.56397/jimr/2022.10.02
Vitamins, Minerals, Supplements and Dietary Approaches
(2003) · Focus on Alternative and Complementary Therapies · doi:10.1211/fact.2003.00198
Age-Related Neurodegenerative Diseases
Sivagurunathan, N., & Latchoumycandane, C. (2023) · Springer eBooks · doi:10.1007/978-981-99-0534-8_17
Role of Antioxidants in the Management of Migraine Pain
Dhar, A. K., & Kar, S. S. (2024) · Springer eBooks · doi:10.1007/978-981-97-4529-6_7
Charnolosome in Parkinson's disease
SHARMA, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21752-4.00043-2
Neumane, S. (2011) · theses.fr (ABES) · doi:10.70675/4cb9b747z6b13z46eazb3cbzb58a8bffabf2
Bougea, A. M. (2026) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864261465665
Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases
Tian, Q., Tong, Y., Yu, F., & Hu, X. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71118
Metadata
- Authors
- Shults, C. W., Haas, R. H., Passov, D., & Beal, M. F.
- Affiliations
- United States Department of Veterans Affairs (US)
- University of California San Diego (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Shults, Clifford W.
- ORCID
- Haas, Richard H.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1997-08
- Volume
- 42
- Issue
- 2
- Pages
- 261-264
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2084464741
- Cited by
- 326
- References
- 15
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 8 · 2022: 12 · 2021: 14 · 2020: 10 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 6 · 2015: 11 · 2014: 16 · 2013: 14 · 2012: 11
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns032365-03, 5r01ns029504-03)
- U.S. Public Health Service (P01 12992)
- National Institute of Neurological Disorders and Stroke (R01 NS32365, R01 NS29504)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- coenzyme Q10, Parkinson's disease, mitochondrial complex I, platelet mitochondria, mitochondrial electron transport chain, mitochondrial dysfunction
- MeSH terms
- Blood Platelets, Coenzymes, Female, Humans, Male, Mitochondria, Multienzyme Complexes, Oxidoreductases, Parkinson Disease, Reference Values, Succinate Dehydrogenase, Electron Transport Complex III, Ubiquinone, NAD(P)H Dehydrogenase (Quinone), Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
